Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Hepatitis

  Free Subscription


13.08.2018

2 AIDS
2 Ann Intern Med
1 BMC Gastroenterol
1 Clin Infect Dis
2 Dig Dis Sci
4 Eur J Gastroenterol Hepatol
1 Gastroenterology
1 Gut
7 Hepatology
5 J Hepatol
6 J Med Virol
5 J Virol
1 Nature
2 PLoS One
1 Vaccine


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AIDS

  1. LLEDO GM, Carrasco I, Benitez-Gutierrez LM, Arias A, et al
    Regression of liver fibrosis after curing chronic hepatitis C with oral antivirals in patients with and without HIV coinfection.
    AIDS. 2018 Aug 8. doi: 10.1097/QAD.0000000000001966.
    PubMed     Text format     Abstract available

  2. PRICE JC, Seaberg EC, Stosor V, Witt MD, et al
    AST-to-platelet ratio index increases significantly 3 years prior to liver-related death in HIV-hepatitis-coinfected men.
    AIDS. 2018 Aug 8. doi: 10.1097/QAD.0000000000001977.
    PubMed     Text format     Abstract available


    Ann Intern Med

  3. SHARIF A
    Transplanting Kidneys From Hepatitis C-Infected Donors Into Uninfected Recipients: Ready for the Mainstream.
    Ann Intern Med. 2018 Aug 7. pii: 2696496. doi: 10.7326/M18-1781.
    PubMed     Text format    

  4. REESE PP, Abt PL, Blumberg EA, Van Deerlin VM, et al
    Twelve-Month Outcomes After Transplant of Hepatitis C-Infected Kidneys Into Uninfected Recipients: A Single-Group Trial.
    Ann Intern Med. 2018 Aug 7. pii: 2696495. doi: 10.7326/M18-0749.
    PubMed     Text format     Abstract available


    BMC Gastroenterol

  5. LI W, Jia L, Zhao X, Wu X, et al
    Efficacy and safety of tenofovir in preventing mother-to-infant transmission of hepatitis B virus: a meta-analysis based on 6 studies from China and 3 studies from other countries.
    BMC Gastroenterol. 2018;18:121.
    PubMed     Text format     Abstract available


    Clin Infect Dis

  6. WITTKOP L
    Endstage liver disease in HIV infection: an avoidable burden?
    Clin Infect Dis. 2016.
    PubMed     Text format    


    Dig Dis Sci

  7. SIKAVI C, Najarian L, Saab S
    Similar Sustained Virologic Response in Real-World and Clinical Trial Studies of Hepatitis C/Human Immunodeficiency Virus Coinfection.
    Dig Dis Sci. 2018 Aug 9. pii: 10.1007/s10620-018-5215.
    PubMed     Text format     Abstract available

  8. TRAN AN, Sachdev R, Fricker ZP, Leber M, et al
    Intensive Pharmacy Care Improves Outcomes of Hepatitis C Treatment in a Vulnerable Patient Population at a Safety-Net Hospital.
    Dig Dis Sci. 2018 Aug 4. pii: 10.1007/s10620-018-5231.
    PubMed     Text format     Abstract available


    Eur J Gastroenterol Hepatol

  9. ZHANG X, Qi X, Yoshida EM, Mendez-Sanchez N, et al
    Ischemic stroke in liver cirrhosis: epidemiology, risk factors, and in-hospital outcomes.
    Eur J Gastroenterol Hepatol. 2018;30:233-240.
    PubMed     Text format     Abstract available

  10. ALI N, Hussain W, Hayat A, Shah T, et al
    Prevalence and risk factors of hepatitis B and C viruses among haemodialysis patients: a multicentric study.
    Eur J Gastroenterol Hepatol. 2018 Aug 3. doi: 10.1097/MEG.0000000000001220.
    PubMed     Text format     Abstract available

  11. GAYAM V, Tiongson B, Khalid M, Mandal AK, et al
    Sofosbuvir based regimens in the treatment of chronic hepatitis C genotype 1 infection in African-American patients: a community-based retrospective cohort study.
    Eur J Gastroenterol Hepatol. 2018 Aug 9. doi: 10.1097/MEG.0000000000001233.
    PubMed     Text format     Abstract available

  12. EL-NAHAAS SM, Fouad R, Elsharkawy A, Khairy M, et al
    High sustained virologic response rate using generic directly acting antivirals in the treatment of chronic hepatitis C virus Egyptian patients: single-center experience.
    Eur J Gastroenterol Hepatol. 2018 Aug 9. doi: 10.1097/MEG.0000000000001228.
    PubMed     Text format     Abstract available


    Gastroenterology

  13. YOSHIKAWA T, Ohana M, Fukuda A
    High fever after radiofrequency ablation of hepatocellular carcinoma.
    Gastroenterology. 2018 Jan 31. pii: S0016-5085(18)30134.
    PubMed     Text format    


    Gut

  14. LOCARNINI S, Raimondo G
    How infectious is the hepatitis B virus? Readings from the occult.
    Gut. 2018 Aug 1. pii: gutjnl-2018-316900. doi: 10.1136/gutjnl-2018-316900.
    PubMed     Text format    


    Hepatology

  15. HUSSAINI T, Krajden M, Mitchell RA, Yoshida EM, et al
    Transplanting Hepatitis C seropositive, nucleic acid test negative donor organs into hepatitis C negative recipients.
    Hepatology. 2018 Aug 2. doi: 10.1002/hep.30121.
    PubMed     Text format     Abstract available

  16. REFOLO G, Ciccosanti F, Di Rienzo M, Perdomo AB, et al
    Negative regulation of MAVS-mediated antiviral signaling by the mitochondrial protein LRPPRC during HCV infection.
    Hepatology. 2018 Aug 2. doi: 10.1002/hep.30149.
    PubMed     Text format     Abstract available

  17. TERRAULT N, Brown R Jr, Lok A, Wong J, et al
    Preventing Perinatal Transmission of Hepatitis B Necessitates Consideration of Antiviral Treatment in Pregnancy.
    Hepatology. 2018 Aug 2. doi: 10.1002/hep.30137.
    PubMed     Text format     Abstract available

  18. GANE EJ, Stedman CA, Schwabe C, Vijgen L, et al
    Short Duration AL-335, Odalasvir, With/Without Simeprevir, in Patients With HCV GT1 or 3 Infection Without Cirrhosis.
    Hepatology. 2018 Aug 2. doi: 10.1002/hep.30126.
    PubMed     Text format     Abstract available

  19. MUBARAK G, Ferstenberg R
    The efficacy of Tenofivir to prevent perinatal transmission in chronic hepatitis B mothers'. a clinical perspective.
    Hepatology. 2018 Aug 2. doi: 10.1002/hep.30138.
    PubMed     Text format     Abstract available

  20. LI CL, Li CY, Lin YY, Ho MC, et al
    Androgen Receptor Enhances Hepatic TERT Transcription after Hepatitis B Virus Integration or Point Mutation in Promoter Region.
    Hepatology. 2018 Aug 2. doi: 10.1002/hep.30201.
    PubMed     Text format     Abstract available

  21. MURRAY KF, Balistreri WF, Bansal S, Whitworth S, et al
    Safety and Efficacy of Ledipasvir-Sofosbuvir With or Without Ribavirin for Chronic Hepatitis C in Children Ages 6-11.
    Hepatology. 2018 Aug 2. doi: 10.1002/hep.30123.
    PubMed     Text format     Abstract available


    J Hepatol

  22. KIM JH, Kim YD, Lee M, Jun BG, et al
    Modified PAGE-B score predicts the risk of hepatocellular carcinoma in Asians with chronic hepatitis B on antiviral therapy.
    J Hepatol. 2018 Jul 31. pii: S0168-8278(18)32274.
    PubMed     Text format     Abstract available

  23. ZHU S, Zhao P
    Reply to: "Immunotolerant children with chronic hepatitis B - To treat or not - The dilemma continues".
    J Hepatol. 2018 Aug 4. pii: S0168-8278(18)32265.
    PubMed     Text format    

  24. HERZER K, Gerken G, Kroy D, Tacke F, et al
    Impact of direct-acting antiviral therapy on the need for liver transplantation related to hepatitis C in Germany.
    J Hepatol. 2018 Aug 6. pii: S0168-8278(18)32179.
    PubMed     Text format    

  25. LAL BB, Sood V, Khanna R, Alam S, et al
    Immunotolerant children with chronic hepatitis B - To treat or not - The dilemma continues.
    J Hepatol. 2018 Aug 6. pii: S0168-8278(18)32173.
    PubMed     Text format    

  26. BHAVE P, Buckle A, Sandhu S, Sood S, et al
    Mortality due to immunotherapy related hepatitis.
    J Hepatol. 2018 Aug 6. pii: S0168-8278(18)32165.
    PubMed     Text format    


    J Med Virol

  27. YANG D, Hu T, Wu X, Li K, et al
    Droplet digital polymerase chain reaction for detection of clinical hepatitis B virus DNA samples.
    J Med Virol. 2018 Aug 7. doi: 10.1002/jmv.25276.
    PubMed     Text format     Abstract available

  28. PRAKASH S, Shukla S, Ramakrishna V, Jain A, et al
    Distribution of Hepatitis C Genotypes in Uttar Pradesh, India; Rare Genotype 4 Detected.
    J Med Virol. 2018 Aug 7. doi: 10.1002/jmv.25277.
    PubMed     Text format     Abstract available

  29. FLORES GL, Cruz HM, Miguel JC, Potsch DV, et al
    Assessing Hepatitis B immunity using dried blood spot samples from HIV(+) individuals.
    J Med Virol. 2018 Aug 7. doi: 10.1002/jmv.25275.
    PubMed     Text format     Abstract available

  30. LU T, Han Y, Zhang R, Zhang K, et al
    Quantitative detection of hepatitis C virus RNA in urine of patients with chronic hepatitis C using a novel real-time PCR assay.
    J Med Virol. 2018 Aug 9. doi: 10.1002/jmv.25280.
    PubMed     Text format     Abstract available

  31. KAHYESH-ESFANDIARY R, Sadigh ZA, Esghaei M, Bastani MN, et al
    Detection of HCV Genome in Peripheral Blood Mononuclear Cells of Iranian Seropositive and HCV RNA negative in Plasma of Patients with Beta-thalassemia Major: Occult HCV Infection.
    J Med Virol. 2018 Aug 9. doi: 10.1002/jmv.25279.
    PubMed     Text format     Abstract available

  32. AKUTA N, Sezaki H, Suzuki F, Fujiyama S, et al
    Favorable efficacy of glecaprevir plus pibrentasvir as salvage therapy for HCV failures to prior direct-acting antivirals regimens.
    J Med Virol. 2018 Aug 9. doi: 10.1002/jmv.25278.
    PubMed     Text format     Abstract available


    J Virol

  33. MOUSTAFA RI, Haddad JG, Linna L, Hanoulle X, et al
    Functional study of the C-terminal part of hepatitis C virus E1 ectodomain.
    J Virol. 2018 Aug 1. pii: JVI.00939-18. doi: 10.1128/JVI.00939.
    PubMed     Text format     Abstract available

  34. ANANG S, Kaushik N, Hingane S, Kumari A, et al
    Potent inhibition of hepatitis E virus release by a cyclic peptide inhibitor of the interaction between viral open reading frame 3 protein and host tumor susceptibility gene 101.
    J Virol. 2018 Aug 1. pii: JVI.00684-18. doi: 10.1128/JVI.00684.
    PubMed     Text format     Abstract available

  35. RUAN L, Hadden JA, Zlotnick A
    Assembly properties of Hepatitis B Virus core protein mutants correlate with their resistance to assembly-directed antivirals.
    J Virol. 2018 Aug 8. pii: JVI.01082-18. doi: 10.1128/JVI.01082.
    PubMed     Text format     Abstract available

  36. HSU SC, Tsai CN, Lee KY, Pan TC, et al
    Sequential S232/S235/S238 Phosphorylation of the Hepatitis C Virus Nonstructural Protein 5A.
    J Virol. 2018 Aug 8. pii: JVI.01295-18. doi: 10.1128/JVI.01295.
    PubMed     Text format     Abstract available

  37. SUR S, Sasaki R, Devhare P, Steele R, et al
    Association between microRNA-373 and long non-coding RNA NORAD in hepatitis C virus infected hepatocytes impairs Wee1 expression for growth promotion.
    J Virol. 2018 Aug 8. pii: JVI.01215-18. doi: 10.1128/JVI.01215.
    PubMed     Text format     Abstract available


    Nature

  38. MORE B
    Drug executives should take a Hippocratic oath.
    Nature. 2018;555:561.
    PubMed     Text format    


    PLoS One

  39. MASSAQUOI TA, Burke RM, Yang G, Lakoh S, et al
    Cross sectional study of chronic hepatitis B prevalence among healthcare workers in an urban setting, Sierra Leone.
    PLoS One. 2018;13:e0201820.
    PubMed     Text format     Abstract available

  40. DU Z, Dong J, Bi J, Bai R, et al
    Predictive value of the preoperative neutrophil-to-lymphocyte ratio for the development of hepatocellular carcinoma in HBV-associated cirrhotic patients after splenectomy.
    PLoS One. 2018;13:e0195336.
    PubMed     Text format     Abstract available


    Vaccine

  41. DOBRICA MO, Lazar C, Paruch L, van Eerde A, et al
    Oral administration of a chimeric Hepatitis B Virus S/preS1 antigen produced in lettuce triggers infection neutralizing antibodies in mice.
    Vaccine. 2018 Aug 3. pii: S0264-410X(18)31081.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: